NCT00377520
A Trial for Patients With Advanced/Recurrent Endometrial Cancer treatment 2 completed NCT00267488
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer treatment 2 completed NCT02630823
MK-3475 Immunotherapy in Endometrial Carcinoma treatment 1 completed NCT06003231
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 treatment 2 recruiting NCT06586957
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) treatment 1 / 2 recruiting NCT05007106
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) treatment 2 active_not_recruiting NCT06400472
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03884101
Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) treatment 3 active_not_recruiting NCT04865289
Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study treatment 3 active_not_recruiting NCT05129969
Registry Platform Ovarian and Endometrial Cancer No drug interventions Not Available Not Available recruiting NCT04008797
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor treatment 1 / 2 recruiting NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04976634
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) treatment 2 recruiting NCT05194072
A Study of SGN-B7H4V in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05974995
Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer No drug interventions treatment Not Available recruiting NCT05334303
The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study No drug interventions Not Available Not Available unknown_status NCT04665921
A Study of SGN-STNV in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00288821
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology No drug interventions Not Available Not Available completed NCT05770102
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition treatment 2 / 3 recruiting NCT04763902
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer No drug interventions prevention Not Available completed NCT05687084
Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial No drug interventions treatment Not Available recruiting NCT01820884
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma No drug interventions treatment Not Available active_not_recruiting NCT05173987
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15) treatment 3 active_not_recruiting NCT04870177
Study of AK112 in the Treatment of Advanced Gynecological Tumors treatment 2 active_not_recruiting NCT03917147
Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination No drug interventions Not Available Not Available completed NCT02387645
LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma No drug interventions diagnostic Not Available completed NCT00936598
Sleep and Endometrial Cancer supportive_care Not Available terminated NCT05634798
An Observational Study Based on Endometrial Cancer Risk Screening Model No drug interventions Not Available Not Available unknown_status NCT00250783
Pre-Clinical Models in Gynecological Tumors A Tissue Repository No drug interventions Not Available Not Available completed NCT05657483
Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study No drug interventions Not Available Not Available recruiting NCT03951415
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer treatment 2 unknown_status NCT03543215
Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? No drug interventions Not Available Not Available recruiting NCT04269200
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer treatment 3 active_not_recruiting NCT05229900
A Study of SGN-ALPV in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03291275
Survival Outcomes of Uterine Malignancies in Chinese Population No drug interventions Not Available Not Available unknown_status NCT00250770
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis No drug interventions Not Available Not Available withdrawn NCT03291106
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer No drug interventions Not Available Not Available unknown_status NCT03517449
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) treatment 3 active_not_recruiting NCT06379113
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients treatment 2 / 3 recruiting NCT01820858
The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma treatment 3 active_not_recruiting NCT06409039
POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation No drug interventions Not Available Not Available enrolling_by_invitation NCT06532539
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma treatment 2 recruiting NCT02512848
The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period No drug interventions Not Available Not Available unknown_status NCT03207126
Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? No drug interventions diagnostic Not Available unknown_status NCT03207074
Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? No drug interventions diagnostic Not Available completed NCT01549782
Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. No drug interventions prevention Not Available completed NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) No drug interventions treatment 1 / 2 terminated NCT04972682
[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer No drug interventions treatment Not Available completed NCT02288676
DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics No drug interventions Not Available Not Available recruiting NCT02494791
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer No drug interventions screening Not Available active_not_recruiting NCT01888562
Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma treatment Not Available withdrawn NCT02433080
Diet and Physical Activity in Uterine Cancer Survivors No drug interventions supportive_care Not Available completed NCT00050440
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma treatment 2 completed NCT03766672
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique No drug interventions Not Available Not Available completed NCT02725268
A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer treatment 2 completed NCT03270995
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study No drug interventions supportive_care Not Available completed NCT05682950
Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer No drug interventions treatment 2 active_not_recruiting NCT05869123
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer No drug interventions treatment 1 / 2 active_not_recruiting NCT06363708
Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer treatment Not Available not_yet_recruiting NCT06502743
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer treatment 2 not_yet_recruiting NCT01847703
Robotic Versus Abdominal Surgery for Endometrial Cancer No drug interventions treatment Not Available completed NCT00391664
Questionnaire Study for Gynecological Cancer Survivors No drug interventions Not Available Not Available unknown_status NCT00178802
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers No drug interventions treatment 2 unknown_status NCT06521684
Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT01460979
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma treatment 2 completed NCT03112733
Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers No drug interventions Not Available Not Available unknown_status NCT00987051
Sentinel Node and Endometrial Cancer No drug interventions diagnostic Not Available completed NCT04634877
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) treatment 3 active_not_recruiting NCT00598845
Molecular Markers in Treatment in Endometrial Cancer No drug interventions Not Available Not Available unknown_status NCT03207061
Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? No drug interventions diagnostic Not Available unknown_status NCT06126393
MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT05945407
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer No drug interventions treatment Not Available recruiting NCT04867109
HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding No drug interventions Not Available Not Available unknown_status NCT04995809
Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome No drug interventions Not Available Not Available active_not_recruiting NCT03005015
Lenvatinib in Second Line Endometrial Carcinoma treatment 2 withdrawn NCT03570437
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? treatment 2 unknown_status NCT02690259
Sentinel Lymph Node Detection in Endometrial Cancer No drug interventions diagnostic Not Available completed NCT05793749
Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy No drug interventions prevention Not Available recruiting NCT05375136
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients No drug interventions Not Available Not Available completed NCT01178736
Early Detection of Cancers in Low Resource Countries No drug interventions Not Available Not Available unknown_status NCT03276013
Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer treatment 2 completed NCT01013324
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma treatment 2 completed NCT01969396
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology No drug interventions Not Available Not Available terminated NCT00341458
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics No drug interventions Not Available Not Available completed NCT05316935
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients treatment 2 / 3 recruiting NCT04570839
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. treatment 1 / 2 completed NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice No drug interventions Not Available Not Available terminated NCT02676726
STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer No drug interventions treatment Not Available completed NCT01810874
STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer No drug interventions Not Available Not Available completed NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT05588076
Endometrial Lesions Predictions No drug interventions Not Available Not Available active_not_recruiting NCT02564276
Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer No drug interventions diagnostic 3 completed NCT01717391
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers No drug interventions treatment 2 completed NCT06023862
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) treatment 2 recruiting NCT05977829
Endometrial Malignancy in Breast Cancer Patients With or Without AUB No drug interventions Not Available Not Available completed NCT02865889
Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications No drug interventions Not Available Not Available completed NCT03000192
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life No drug interventions Not Available Not Available unknown_status NCT05795244
Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) treatment 2 recruiting NCT04403867
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. No drug interventions Not Available Not Available recruiting NCT02724501
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer No drug interventions Not Available Not Available completed NCT05067972
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT01420081
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer treatment 2 terminated NCT00299481
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease No drug interventions Not Available Not Available unknown_status NCT06171581
Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure No drug interventions supportive_care Not Available not_yet_recruiting NCT03778255
Sentinel Lymph Node Mapping In Endometrial Cancer No drug interventions diagnostic Not Available unknown_status NCT00750672
Follow-up Care After Treatment for Endometrial Cancer No drug interventions Not Available Not Available completed NCT02822833
The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer No drug interventions diagnostic Not Available unknown_status